444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer

C.Mita; M.Goldston; J.Kuhn; M.J.Egorin; M.Beeram; A.Patnaik; M.M.Mita; J.S.DeBono; E.K.Rowinsky; A.W.Tolcher

首页> 外文期刊>European Journal of Cancer Supplements >444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer

【24h】

444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer

机译：444奥利美森钠联合奥沙利铂，5-FU和亚叶酸钙（FOLFOX4方案）在晚期大肠癌患者中进行的I / II期研究

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2004年第8期|共1页
作者
C.Mita; M.Goldston; J.Kuhn; M.J.Egorin; M.Beeram; A.Patnaik; M.M.Mita; J.S.DeBono; E.K.Rowinsky; A.W.Tolcher;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase II randomized study of combined infusional leucovorin sodium and 5-FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer [J] . BleibergH., VandebroekA., DeleuI., Acta gastro-enterologica Belgica . 2012,第1期

机译：转移性结直肠癌患者联合输注亚叶酸钙钠和5-FU与亚叶酸钙联合5-FU联合伊立替康或奥沙利铂的II期随机研究
2. Randomized, Phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) Versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study [J] . DouillardJ.-Y., SienaS., CassidyJ., Journal of Clinical Oncology . 2010,第31期

机译：帕尼单抗与氟尿嘧啶，亚叶酸和奥沙利铂（FOLFOX4）输注的随机，III期试验与单独使用FOLFOX4作为先前未经治疗的转移性结直肠癌患者的一线治疗：PRIME研究
3. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer [J] . GravalosC., SalutA., García-GircónC., Clinical & translational oncology : . 2012,第8期

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加raltitrexed（TOMOX）作为晚期大肠癌一线化疗的比较
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. A Phase 1/2 Study of Ixazomib as a Replacement for Bortezomib or Carfilzomib for Multiple Myeloma Patients Recently Relapsed or Refractory to Their Last Combination Regimen Containing Either Bortezomib or Carfilzomib [D] . Forouzan, Eli. 2020

机译：Ixazomib的第1/2期作为替代品髓鞘或胭脂瘤患者的替代品的替代物，最近对含有Bortezomib或Carfilzomib的最后组合方案复发或难治
6. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer [O] . Cristina Gravalos, Antonieta Salut, Carlos García-Girón, -1

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加拉替曲定（TOMOX）作为晚期大肠癌一线化疗的比较
7. A randomized phase II study to compare oxaliplatin plus 5-fluorouracil and leucovorin (FOLFOX4) versus oxaliplatin plus raltitrexed (TOMOX) as first-line chemotherapy for advanced colorectal cancer [O] . Cristina Gravalos, Antonieta Salut, Carlos García-Girón, 2012

机译：一项II期随机研究比较奥沙利铂加5-氟尿嘧啶和亚叶酸（FOLFOX4）与奥沙利铂加拉替曲定（TOMOX）作为晚期大肠癌一线化疗的比较

444 A phase I/II study of oblimersen sodium in combination with oxaliplatin, 5-FU and leucovorin (FOLFOX4 regimen) in patients with advanced colorectal cancer

著录项

相似文献

相关主题

期刊订阅